iShares Neuroscience and Healthcare ETF
IBRN
3 hedge funds and large institutions have $2.82M invested in iShares Neuroscience and Healthcare ETF in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
11% more capital invested
Capital invested by funds: $2.54M → $2.82M (+$276K)
5.13% less ownership
Funds ownership: 63.3% → 58.17% (-5.1%)
25% less funds holding
Funds holding: 4 → 3 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$2.77K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$211K |
| 2 |
PS
Principal Securities
Des Moines,
Iowa
|
-$19.6K |
| 3 |
HI
Harbour Investments
Madison,
Wisconsin
|
-$1.47K |
IBRN Hedge Fund Activity: Q4 2025 in Review
3 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in iShares Neuroscience and Healthcare ETF (IBRN) for Q4 2025, worth a combined $2.82M — up 11% from $2.54M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of IBRN and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest buyer was UBS Group, opening a new position worth an estimated $2.77K. The largest seller was BlackRock, cutting an estimated $211K.
- 3 institutional investors held iShares Neuroscience and Healthcare ETF (IBRN) as of Q4 2025, down from 4 in Q3 2025.
- Funds reported $2.82M of iShares Neuroscience and Healthcare ETF stock for Q4 2025, up 11% quarter-over-quarter.
- 1 fund opened new iShares Neuroscience and Healthcare ETF positions in Q4 2025 and 2 closed out, a net change of -1 holder.
- The largest iShares Neuroscience and Healthcare ETF buyer in Q4 2025 was UBS Group, an estimated $2.77K added.
- The largest iShares Neuroscience and Healthcare ETF seller in Q4 2025 was BlackRock, an estimated $211K sold.
Based on aggregated 13F filings for Q4 2025.